Letters Reframing relations with Pharma

Author’s reply

BMJ 2009; 338 doi: http://dx.doi.org/10.1136/bmj.b768 (Published 24 February 2009) Cite this as: BMJ 2009;338:b768
  1. Joe Collier, emeritus professor of medicines policy1
  1. 1St George’s, University of London, London SW17 0RE
  1. jcollier{at}sgul.ac.uk

    Richard Horton’s letter serves only to strengthen my view that his working party and its processes were flawed.1 2 He does not quibble with most of my observations. His two concerns are with my comments that “the interests of patients seem to have been a secondary consideration,” and that “there is little direct criticism of industry.”

    Ian Gilmore, president of the Royal College of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial